Get the tools used by (smart)2 investors.

Genomma Lab Internacional SAB De CVBMV:LABB

Mexico / Healthcare / Pharmaceuticals

Join now and get access to the full platform

Exchange Data

Hide this widget
22.33 MXN
Price
-0.19 (-0.84%)
Day change
13.90 - 29.18
52-week range

Summary of Genomma Lab Internacional SAB De CV

Hide this widget

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and ...

Dec 31, 2024
Latest Report
Apr 30, 2025
Next Earnings

Price History

Chart Gallery
Hide this widget
Loading chart...

Data Explorer

Hide this widget

Peer Benchmarks

Hide this widget
  LAB B Peers Sector
Market Cap
22.019 B72.768 B1.263 B
Price % of 52 Week High
77.1%75.5%59.8%
Dividend Yield
3.6%3.0%0.0%
Shareholder Yield
10.6%3.7%-0.7%
1 Year Price Total Return
62.7%5.0%-13.6%
Beta (5 Year)
0.550.490.64

Finbox Fair Value

Hide this widget
What is Finbox Fair Value?
A stock's fair value is its real or underlying intrinsic worth.
Read more about Finbox's Fair Value methodology.
MXN
Average
Upside
Uncertainty
You need an account to use this feature
Sign Up
Or
Log In

Financial Health

Health Details
Hide this widget
GREAT
Financial Health for Genomma Lab Int is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developing economic markets.

Financial Models for Genomma Lab Internacional SAB De CV

Model Gallery
Hide this widget

Historical Financials

Full Financials
Hide this widget
(presentment in millions)Trailing Twelve MonthsFiscal Quarters
Period EndingDec-22Dec-23Dec-24Dec-23Dec-24
Income Statement
Revenue16,82016,46718,6073,5254,666
Operating Income3,2443,2583,9826971,013
Net Profit1,3891,0852,137(61)473
Diluted EPS1.401.132.18-0.0650.48
EBITDA3,4713,4854,3427341,134
Balance Sheet
Cash & ST Invest.1,4971,6552,2901,6552,290
Current Assets11,31210,67012,93610,67012,936
Total Assets21,60720,73824,08320,73824,083
Current Liabilities9,3566,6226,7536,6226,753
Total Liabilities11,45411,29712,49411,29712,494
Total Equity10,1539,44111,5899,44111,589
Total Debt6,4416,2396,4886,2396,488
Cash Flow Statement
Cash Flow Operations2,0552,2473,0348191,285
Cash From Investing(488)(302)(732)(317)(31)
Cash From Financing(1,362)(1,677)(1,591)(679)(619)
Free Cash Flow1,6522,0092,7637551,117

Analyst Notes

April 16, 2025
Hide this widget
    All rights reserved. Terms Of Use